Sign in
4

Changes in Ownership

C4 Therapeutics, Inc. Filed Acc 0001662579-23-000107

Director acquired 8,089 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
GROGAN DONNA ROY Director 2023-10-02 Grant or award +8,089 $1.70 $13,751 19,827 D
Loading xslF345X05/wk-form4_1696364777.xml…